Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00146
|
|||||
| Drug Name |
Deflazacort
|
|||||
| Synonyms |
Deflan (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Duchenne muscular dystrophy [ICD11: 8C70.1] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C25H31NO6
|
|||||
| Canonical SMILES |
CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C
|
|||||
| InChI |
InChI=1S/C25H31NO6/c1-13-26-25(20(30)12-31-14(2)27)21(32-13)10-18-17-6-5-15-9-16(28)7-8-23(15,3)22(17)19(29)11-24(18,25)4/h7-9,17-19,21-22,29H,5-6,10-12H2,1-4H3
|
|||||
| InChIKey |
FBHSPRKOSMHSIF-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 14484-47-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 441.5 | Topological Polar Surface Area | 102 | ||
| Heavy Atom Count | 32 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
2
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| ChEBI ID |
CHEBI:135720
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Deflazacort was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG01665) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.